NEW YORK, March 21, 2023 /PRNewswire/ -- The life science software market size is forecast to grow by USD 3,967.58 million between 2022 and 2027. However, the growth momentum will be accelerating at a CAGR of 8.1% during the forecast period. The market is segmented by end-user (pharmaceutical, biotechnology, and others), deployment (cloud-based and on-premise), and geography (North America, Europe, APAC, South America, and Middle East and Africa).

The market will witness maximum growth in the pharmaceutical segment during the forecast period. Pharmaceutical companies are the major end-users in the market. They adopt life sciences software to enhance existing ERP, improve the capabilities of logistic partners, and collaborate with trading partners such as contract packagers. Life sciences software solutions also help pharmaceutical companies throughout the product lifecycle. They lower the time-to-market, speed up research and drug discovery, and streamline commercial operations. All these factors are driving the growth of the segment. For more insights on the historic data (2017 to 2021) and forecast market size (2023 to 2027) – Request a report sample

Company Profiles

The global life science software market is fragmented due to the presence of several global and regional players. Large vendors are entering partnerships and working in collaboration with each other to improve their market presence. They are also acquiring small businesses to expand their customer base and improve market shares. These factors will increase the competition in the market during the forecast period.

The life science software market report includes information on the key products and recent developments of leading vendors, including:

• Cegedim SA. - The company offers life science software such as ActivCloud services, ActivInfinite, iGestion, MyDigitalsales, Hospitalis, and Arkevia.

• Dassault Systemes SE - The company offers life science software such as 3DEXCITE, 3DVIA, BIOVIA, CATIA, and 3DEXPERIENCE.

• Deloitte Touche Tohmatsu Ltd. - The company offers life science software called ConvergeHEALTH software.

• DXC Technology Co. - The company offers life science software through life science analytics, security, cloud, IT outsourcing, and ROI-focused applications.

Regional Analysis

By region, the global life science software market is segmented into North America, Europe, APAC, South America, and Middle East and Africa. North America will account for 49% of market growth during the forecast period. The region is home to some of the major vendors such as SAS Institute Inc., Oracle Corp., and Veeva Systems Inc. In addition, enterprises in the region are early adopters of advanced technologies, such as machine learning, predictive analytics, and quantum and cognitive computing, across business processes. This has led to an increase in the adoption of automation solutions across all business verticals, including the life sciences industry. All these factors are driving the growth of the life science software market in North America.

Market Landscape

The market is driven by factors such as the growing focus on storing patient information, the increasing need for improving operational efficiency and increasing technological innovations. However, frequent changes in mandates will challenge the growth of the market.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

• By end-user, the market is segmented into pharmaceutical, biotechnology, and others.

• By deployment, the market is segmented into cloud-based and on-premise.

• By geography, the market is segmented into North America, Europe, APAC, South America, and Middle East and Africa.

Why Buy?

• Add credibility to strategy

• Analyzes competitor's offerings

• Get a holistic view of the market

Grow your profit margin with Technavio – Buy the Report!

What are the key data covered in this life science software market report?

• CAGR of the market during the forecast period.

• Detailed information on factors that will drive the growth of the market between 2023 and 2027

• Precise estimation of the size of the life science software market and its contribution to the parent market.

• Accurate predictions about upcoming trends and changes in consumer behavior.

• Growth of the market across North America, Europe, APAC, South America, and Middle East and Africa.

• A thorough analysis of the market's competitive landscape and detailed information about vendors.

• Comprehensive analysis of factors that will challenge the growth of life science software market vendors.

Related Reports:

• The laboratory information management system (LIMS) market is estimated to grow at a CAGR of 9.08% between 2022 and 2027. The size of the market is forecast to increase by USD 907.08 million. The market is segmented by deployment (on-premise and cloud-based), component (software and services), and geography (North America, Europe, Asia, and Rest of World (ROW)).

• The oncology information systems (OIS) market size is expected to increase by USD 1.27 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.38%. The market is segmented by product (software and services) and geography (North America, APAC, Europe, South America, and MEA).

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging
technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to
Technavio Insights

Browse through Technavio's Information Technology Market Reports

Table of contents:

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition

• 3.2 Market segment analysis

• 3.3 Market size 2022

• 3.4 Market outlook: Forecast for 2022-2027

4 Historic Market Size

• 4.1 Global life science software market 2017 - 2021

• 4.2 End User Segment Analysis 2017 - 2021

• 4.3 Deployment Segment Analysis 2017 - 2021

• 4.4 Geography Segment Analysis 2017 - 2021

• 4.5 Country Segment Analysis 2017 - 2021

5 Five Forces Analysis

• 5.1 Five forces summary

• 5.2 Bargaining power of buyers

• 5.3 Bargaining power of suppliers

• 5.4 Threat of new entrants

• 5.5 Threat of substitutes

• 5.6 Threat of rivalry

• 5.7 Market condition

6 Market Segmentation by End-user

• 6.1 Market segments

• 6.2 Comparison by End-user

• 6.3 Pharmaceutical - Market size and forecast 2022-2027

• 6.4 Biotechnology - Market size and forecast 2022-2027

• 6.5 Others - Market size and forecast 2022-2027

• 6.6 Market opportunity by End-user

7 Market Segmentation by Deployment

• 7.1 Market segments

• 7.2 Comparison by Deployment

• 7.3 Cloud-based - Market size and forecast 2022-2027

• 7.4 On-premise - Market size and forecast 2022-2027

• 7.5 Market opportunity by Deployment

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation

• 9.2 Geographic comparison

• 9.3 North America - Market size and forecast 2022-2027

• 9.4 Europe - Market size and forecast 2022-2027

• 9.5 APAC - Market size and forecast 2022-2027

• 9.6 South America - Market size and forecast 2022-2027

• 9.7 Middle East and Africa - Market size and forecast 2022-2027

• 9.8 US - Market size and forecast 2022-2027

• 9.9 Germany - Market size and forecast 2022-2027

• 9.10 France - Market size and forecast 2022-2027

• 9.11 UK - Market size and forecast 2022-2027

• 9.12 Japan - Market size and forecast 2022-2027

• 9.13 Market opportunity by geography

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape

• 11.3 Landscape disruption

• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered

• 12.2 Market positioning of vendors

• 12.3 ArisGlobal LLC

• 12.4 Cegedim SA.

• 12.5 Dassault Systemes SE

• 12.6 Deloitte Touche Tohmatsu Ltd.

• 12.7 DXC Technology Co.

• 12.8 EPAM Systems Inc.

• 12.9 International Business Machines Corp.

• 12.10 Model N Inc.

• 12.11 Oracle Corp.

• 12.12 PTC Therapeutics Inc.

• 12.13 SAP SE

• 12.14 SAS Institute Inc.

• 12.15 Sryas

• 12.16 Thermo Fisher Scientific Inc.

• 12.17 Veeva Systems Inc.

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist

• 13.3 Currency conversion rates for US$

• 13.4 Research methodology

• 13.5 List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/life-science-software-market-size-to-increase-by-usd-3-967-58-million-between-2022-and-2027-arisglobal-llc-cegedim-sa-among-others-identified-as-key-vendors---technavio-301777754.html

SOURCE Technavio